Symbol Lookup

Monday May 02, 2016 1:50 AM ET. Data delayed 15 minutes.
6.10
-0.42 (-6.44%)
Bid/Lots
6.10/4
Ask/Lots
6.11/7
Open/Prev Close
6.42/6.52
Day Range
6.00-6.58
52-Week Range
4.26-23.61
Vol/Avg Daily Vol
687.6K/1.2M

TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

CARA Headlines

Go
Cara Therapeutics to Announce First Quarter 2016 Financial Results on May 5, 2016
4:30PM ET on Thursday Apr 28, 2016 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that the Company will host a conference call and live audio webcast on Thursday, May 5, 2016, at 4:30 p.m. ET to report first quarter 2016 financial results and provide a corporate update.

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that the Com...

Apr 20, 2016

This Biotech Is Up 300 In Two Months
10:45AM ET on Wednesday Apr 20, 2016 by Accesswire
Companies Mentioned: PPCH, CARA

LAS VEGAS, NV / ACCESSWIRE / April 20, 2016 / Sean Parker just made an incredible donation, and thus created the "Parker Institute for Cancer Immunotherapy."

If you're looking to follow his money into biotechs that are working toward immuno-oncology and peripheral solutions, I think you should strongly consider Propanc Health Group (PPCH).

LAS VEGAS, NV / ACCESSWIRE / April 20, 2016 / Sean Parker just made an incredible donation, and thus created the "Parker Institute for Cancer Immunotherapy."

If you're looking to follow his money into biotechs that are working toward imm...

Stock Futures Maintain Cautious Gains Despite Pressure on Oil
9:04AM ET on Wednesday Apr 20, 2016 by MT Newswires
Companies Mentioned: INTC, KO, LXK, YHOO, ANGI, CAMP, CARA, VMW
09:04 AM EDT, 04/20/2016 (MT Newswires) -- U.S. stock futures were struggling to stay positive for a third straight day as mixed corporate earnings coupled with selling pressure on oil allowed Wall Street only cautious gains. Oil trimmed some of it...
09:04 AM EDT, 04/20/2016 (MT Newswires) -- U.S. stock futures were struggling to stay positive for a third straight day as mixed corporate earnings coupled with selling pressure on oil allowed Wall Street only cautious gains. Oil trimmed some of...
Expansion of Legalized Cannabis Continues at a Torrid Pace in the U.S. and Globally For Leading Markets Worldwide; Company Receives Purchase Order for Medical Marijuana Products
8:30AM ET on Wednesday Apr 20, 2016 by PR Newswire
Companies Mentioned: CBIS, CBDS, TRTC, GWPH, CARA

Global opportunities are promising for legalized marijuana and cannabis sector as revenues continue to thrive behind increased federal & governmental research and development of latest products. Marijuana & Cannabis Companies with current operations and developments of importance in the markets today are New Colombia Resources, Inc. (OTC: NEWC), Cannabis Science, Inc. (OTC: CBIS), Cara Therapeutics (NASDAQ: CARA), Terra Tech Corp. (OTC: TRTC) and Cannabis Sativa Inc. (OTCBB: CBDS).

Global opportunities are promising for legalized marijuana and cannabis sector as revenues continue to thrive behind increased federal & governmental research and development of latest products. Marijuana & Cannabis Companies with curre...

Sector Update: Health Care Stocks Mixed Pre-Bell
8:01AM ET on Wednesday Apr 20, 2016 by MT Newswires
Companies Mentioned: JNJ, MRK, PFE, STJ, ABT, AMGN, CARA
08:01 AM EDT, 04/20/2016 (MT Newswires) -- Top Health-care stocks: JNJ: flat PFE: +0.3% ABT: +1.5% MRK: flat AMGN: -1.7% Health care shares were mixed in pre-market trade Wednesday. In health care stocks news, St. Jude Medical (STJ) reported Q1 a...
08:01 AM EDT, 04/20/2016 (MT Newswires) -- Top Health-care stocks: JNJ: flat PFE: +0.3% ABT: +1.5% MRK: flat AMGN: -1.7% Health care shares were mixed in pre-market trade Wednesday. In health care stocks news, St. Jude Medical (STJ) reported Q...
← Newer12Older →

Peers Headlines

Apr 29, 2016

BRIEF-Agile Therapeutics says Caxton Corp reports 5.4 pct passive stake in company
5:06PM ET on Friday Apr 29, 2016 by Thomson Reuters
Companies Mentioned: AGRX

April 29 (Reuters) - Agile Therapeutics Inc

* Caxton Corporation reports 5.4 percent passive stake in Agile Therapeutics Inc as of April 27, 2016 - SEC...

Apr 28, 2016

National Holdings Soars 38.5%, Agrees to Sell Co to Fortress Biotech for $3.25 Per Share Cash
2:09PM ET on Thursday Apr 28, 2016 by MT Newswires
Companies Mentioned: NHLD, FBIO
02:09 PM EDT, 04/28/2016 (MT Newswires) -- National Holdings (NHLD) rallies 38.5% after the companies said Fortress Biotech (FBIO) will, through its unit FBIO Acquisition, buy National Holdings for $3.25 per share in cash. If the agreement fails ...
BRIEF-National Holdings says will be responsible for a termination fee of $1.8 mln
11:28AM ET on Thursday Apr 28, 2016 by Thomson Reuters
Companies Mentioned: NHLD, FBIO

April 28 (Reuters) - National Holdings Corp

* Says would be responsible for a termination fee of $1.8 million if the merger agreement is terminated

* Sa...

BRIEF-Fortress to buy up to 100 pct of shares of National Holdings
11:24AM ET on Thursday Apr 28, 2016 by Thomson Reuters
Companies Mentioned: NHLD, FBIO

April 28 (Reuters) - National Holdings Corp

* Fortress will offer through unit., to buy up to 100 pct of shares of national holdings at $3.25 per share...

Fortress Biotech and National Holdings Announce Agreement
8:50AM ET on Thursday Apr 28, 2016 by Marketwire
Companies Mentioned: NHLD, FBIO

National Holdings Corporation (NASDAQ: NHLD) ("National Holdings" or "NHLD"), a full-service investment banking and asset management firm, and Fortress Biotech, Inc. (NASDAQ: FBIO) ("Fortress" or "FBIO"), a biopharmaceutical company dedicated t...

Howard I. Scher M.D., Leading Clinical Oncology Expert, Joins the Board of Directors of Asterias Biotherapeutics
7:00AM ET on Thursday Apr 28, 2016 by PR Newswire
Companies Mentioned: AST

Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company with three clinical-stage development programs focused on the emerging field of regenerative medicine, today announced the appointment of Howard I. Scher M.D., one of the w...

Osteoarthritis Pipeline Market H1 2016 Global Review Report
2:00AM ET on Thursday Apr 28, 2016 by PR Newswire
Companies Mentioned: TKPYY, GLPG, GSK, LLY, OMER, PFE, ZBH, MESO, CANF, AKTX, CTIX, CBMG, AST, ABYLY, SVFC, MKGAY, AXSM

New market research titled "Osteoarthritis - Pipeline Review, H1 2016" is a report that provides an overview of the Osteoarthritis's therapeutic pipeline and helps strengthen R&D pipelines by identifying new targets and MOAs to produce firs...

Apr 26, 2016

Asterias Biotherapeutics to Present at Stem Cell Summit 2016
7:00AM ET on Tuesday Apr 26, 2016 by PR Newswire
Companies Mentioned: AST

Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company with three clinical-stage development programs focused on the emerging field of regenerative medicine, today announced that Katharine Spink, Ph.D., Chief Operating Officer,...

Apr 21, 2016

BRIEF-Helocyte says Frank Taffy appointed president and CEO
8:03AM ET on Thursday Apr 21, 2016 by Thomson Reuters
Companies Mentioned: FBIO

April 21 (Reuters) - Fortress Biotech Inc

* Helocyte says Frank Taffy appointed president and chief executive officer Source text for Eikon: Further co...

Helocyte Announces Corporate and Clinical Milestones
7:00AM ET on Thursday Apr 21, 2016 by GlobeNewswire
Companies Mentioned: FBIO

-- Frank Taffy Appointed President and Chief Executive Officer

-- Lead Immunotherapies PepVax and Triplex Advanced into Phase 2

-- Triplex Phase 1 Data Presented at ASH

-- PepVax Phase 1b Data Published in The Lancet

← Newer12Older →